PLG Antibody Blocking peptide
PLG Antibody Blocking peptide
Product Specifications
Product Name Alternative
Plasminogen, Plasmin heavy chain A, Activation peptide, Angiostatin, Plasmin heavy chain A, short form, Plasmin light chain B, PLG
UniProt
P00747
Field of Research
Cardiovascular Research
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence used to generate the antibody orb1929371 was selected from the C-term region of human PLG. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS065999-100ug 100 µg
LRRC61 (NM_001142928) Human Over-expression Lysate
Sign In for Pricing
View Details 
MBS1376774-01 0.02 mg (E-Coli)
Recombinant Hylobates lar Apolipoprotein E (APOE)
Sign In for Pricing
View Details MBS1376774-02 0.02 mg (Yeast)
Recombinant Hylobates lar Apolipoprotein E (APOE)
Sign In for Pricing
View Details MBS1376774-03 0.1 mg (E-Coli)
Recombinant Hylobates lar Apolipoprotein E (APOE)
Sign In for Pricing
View Details MBS1376774-04 0.1 mg (Yeast)
Recombinant Hylobates lar Apolipoprotein E (APOE)
Sign In for Pricing
View Details MBS1376774-05 0.02 mg (Baculovirus)
Recombinant Hylobates lar Apolipoprotein E (APOE)
Sign In for Pricing
View Details